China Pharma Holdings' hepatocyte growth factor has been launched in China after receiving approval from the State Food and Drug Agency.

Source: Inpharma, Volume 1, Number 1541, 2006-06-10 , pp. 19-19(1)

Publisher: Adis International

Buy & download fulltext article:

OR

Price: $37.95 plus tax (Refund Policy)

Keywords: Development-status; Hepatitis-B, treatment; Hepatocyte-growth-factor, therapeutic use; Product-launches; Research-and-development

Document Type: Short communication

Publication date: 2006-01-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page